B
Bull
Bull · 25%OM
$19.05
Precio del escenario
$3.940
-0.145 (-3.67%)Al cierre
Loading chart…
- High
- 4.175
- Open
- 4.110
- VWAP
- 4.01
- Vol
- 146.26K
- Mkt Cap
- 214.13M
- Low
- 3.910
- Amount
- 586.28K
- EV/EBITDA, TTM
- -2.21
Outset Medical, Inc. is a medical technology company. It offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. It designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. The Tablo Console is a proprietary, compact, and mobile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
AI analysis of Outset Medical Inc (OM)
sellOutset Medical Inc is not a good buy right now due to its current price of $3.94, which is significantly below analyst targets of $10 and $6, indicating potential upside. However, the stock has a very low RSI of 24.845, suggesting it is oversold, but the high debt to equity ratio of 101.94% poses a significant risk.
Métricas de valoración
The current forward P/E ratio for Outset Medical Inc (OM) is 0.00, compared to its 5-year average forward P/E of -6.51.
Alphio AI Price Scenarios for OM
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding OM
Cronología de eventos
Noticias
7.007-29PRnewswireHalper Sadeh LLC Investigates Outset Medical Executives' Fiduciary Duties
7.007-06PRnewswireOutset Medical Faces Securities Fraud Investigation Over Misleading FDA Claims
2.007-02NASDAQ.COMBiotech Companies See Significant Stock Gains
- 9.506-19NASDAQ.COM
Outset Medical Shares Surge 25.6% on HCA Deal
5.005-28Yahoo FinanceOsisko Metals Annual Meeting Results Announced
OM FAQ — answered by Alphio AI
Outset Medical, Inc. is a medical technology company. It offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. It designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. The Tablo Console is a proprietary, compact, and mobile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
Outset Medical Inc is not a good buy right now due to its current price of $3.94, which is significantly below analyst targets of $10 and $6, indicating potential upside. However, the stock has a very low RSI of 24.845, suggesting it is oversold, but the high debt to equity ratio of 101.94% poses a significant risk.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.